HUM
20
-4
MCHP
55
-5
CPB
39
-3
CF
44
3
HPE
47
-5
XRAY
26
-11
HIG
64
-2
OMC
51
-2
UAL
45
-2
LMT
74
-3
URI
40
4
MAS
38
-4
ETN
53
-11
GE
71
-7
LNC
25
2
ITW
58
-4
MMM
52
-2
XOM
54
-2
CL
50
-6
BMY
69
-4
HUM
20
-4
MCHP
55
-5
CPB
39
-3
CF
44
3
HPE
47
-5
XRAY
26
-11
HIG
64
-2
OMC
51
-2
UAL
45
-2
LMT
74
-3
URI
40
4
MAS
38
-4
ETN
53
-11
GE
71
-7
LNC
25
2
ITW
58
-4
MMM
52
-2
XOM
54
-2
CL
50
-6
BMY
69
-4
Financhill
Back

Minerva Neurosciences, Inc. 10K Form

Buy
55

NERV
Minerva Neurosciences, Inc.

Last Price:
$6.75
Seasonality Move:
5.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NERV News And Ratings

See the #1 stock for the next 7 days that we like better than NERV

NERV Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-2.9M
Price / Cash Flow: 0
Annual Sales: $-4.94
Price / Book: 0

Profitability

EPS (TTM): -1.85320
Net Income (TTM): $-14M
Gross Margin: $-22.5K
Return on Equity: 0%
Return on Assets: -40.95%

Minerva Neurosciences, Inc. Earnings Forecast

Key Minerva Neurosciences, Inc. Financial Ratios

  • The Interest Expense is 317.06% of Operating Income.
  • Per Share Earnings over the last 13 years have been positive in 7 years.

Minerva Neurosciences, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: NERV
CUSIP: 603380
Website: minervaneurosciences.com

Debt

Debt-to-Equity Ratio: -1.74
Current Ratio: 4.87
Quick Ratio: 4.64

Price-to-Earnings

Trailing P/E Ratio: 36.11
Forward P/E Ratio: 0

NERV Technical Analysis vs Fundamental Analysis

Buy
55
Minerva Neurosciences, Inc. (NERV) is a Buy

Is Minerva Neurosciences, Inc. a Buy or a Sell?